- Work +353 1 691 5000
- Fax +353 1 691 5010
- 18 DUBLIN
- Work +353 (0)1 691 5277
Corporate/Commercial; Life Sciences; Inward Investment.
Colin, who joined the firm as a partner in the Corporate Department in January 2004, has extensive international transactional and other experience particularly in the life sciences and technology sectors. Colin advises a broad range of companies operating in the life sciences and related sectors including biotechnology, pharmaceutical and med tech companies, research institutions and government institutions such as Alimentary Health, Azur Pharma, Elan Corporation, Merrion Pharmaceuticals, NUI Galway and Ovagen Limited. Colin also acts for a number of companies in the Food and Beverage Sectors who are increasingly becoming involved in intellectual property based transactions and related financings. Colin is an active member of the Licensing Executives Society Laws Committee (Britain and Ireland) and the Irish American Chamber of Commerce Research & Development Committee (which has engaged with a number of state agencies). For four years Colin was a member of the Business Law Committee of the Law Society of Ireland. Colin worked as a solicitor with another Dublin law firm before joining Elan Corporation, plc in 1994. From 1996 to 2002 Colin was vice president and general counsel of Elan Pharmaceutical Technologies (Elan’s drug delivery division). In 2002 Colin was promoted to senior vice president and played a leading role in the restructuring of Elan that involved the sale of assets worth in excess of $1.8 billion. Colin was also centrally involved in managing the legal aspects of the SEC investigation into Elan’s accounting policies and the related litigation involving class action suits by some Elan shareholders.
Colin is a member of the Business Law Committee of the Law Society of Ireland.
Colin Sainsbury was educated at Trinity College Dublin and qualified as a solicitor in 1984. He was admitted to the Roll of Solicitors in England and Wales.